China's Medical Exports And Imports Nearly Double In First Half 2011
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - During the first half of 2011, China posted strong export and import growth in its medical products, which include pharmaceutical, active pharmaceutical ingredients, medical devices and traditional Chinese medicines, according to an Aug. 11 report from China's Chamber of Commerce
You may also be interested in...
AstraZeneca Invests $200 Million For Manufacturing Plant In China Medical City
AstraZeneca PLC has announced a plan to invest $200 million to build a new manufacturing plant inside Taizhou, Jiangsu-based China Medical City
AstraZeneca Invests $200 Million For Manufacturing Plant In China Medical City
AstraZeneca PLC has announced a plan to invest $200 million to build a new manufacturing plant inside Taizhou, Jiangsu-based China Medical City
China's Top Device Maker Mindray Enters Critical Care Market; Sees Boosts From Color Ultrasound Devices
Despite a negative impact from political unrest in the Middle East, China's leading medical device maker Mindray Medical International is steaming ahead with solid first quarter growth in both international and Chinese domestic markets. That growth was driven largely by a continued stronghold in its low- to mid-end device market, as well as an emerging footprint in the lucrative high-end segment with its color ultrasound devices